MBX Biosciences: Barclays raises target price to $88 from $70
MBX•Related News
NESR Q2 FY26 diluted EPS rises 85.8% sequentially to USD 0.43; revenue climbs 59.1% year-over-year to USD 520.8 million
NESR•
Procept BioRobotics CEO Larry Wood acquires common shares worth $498,315
PRCT•
Ukraine kills 13, including child, in drone attack on Russian city of Nizhnekamsk, officials say
XLE•
Embraer 2Q26 adjusted net income rises to US$218.6 million; revenue climbs 23% YoY to US$2.24 billion
ERJ•
inTEST Corp Q2 Adjusted EPS USD 0.09
INTT•